Travere Therapeutics Inc. (TVTX)
NASDAQ: TVTX
· Real-Time Price · USD
18.78
-0.04 (-0.21%)
At close: Aug 18, 2025, 3:59 PM
19.05
1.44%
Pre-market: Aug 19, 2025, 04:27 AM EDT
Travere Therapeutics Revenue
Travere Therapeutics reported an annual revenue of $233.18M, reflecting a 60.55% growth. For the quarter ending June 30, 2025, Travere Therapeutics generated $114.45M in revenue.
Revenue (ttm)
233.18M
Revenue Growth
60.55%
Price / Sales Ratio
5.89
Revenue / Employee
605.65K
Employees
385
Market Cap
1.67B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 233.18M | +60.55% |
| Dec 31, 2023 | 145.24M | -31.50% |
| Dec 31, 2022 | 212.02M | -6.80% |
| Dec 31, 2021 | 227.49M | +14.71% |
| Dec 31, 2020 | 198.32M | +13.11% |
| Dec 31, 2019 | 175.34M | +6.75% |
| Dec 31, 2018 | 164.25M | +6.01% |
| Dec 31, 2017 | 154.94M | +15.98% |
| Dec 31, 2016 | 133.59M | +33.74% |
| Dec 31, 2015 | 99.89M | +254.19% |
| Dec 31, 2014 | 28.2M | +Infinity% |
| Dec 31, 2013 | 0 | n/a |
| Dec 31, 2012 | 0 | n/a |
| Feb 29, 2012 | 0 | n/a |
| Feb 28, 2011 | 0 | n/a |
| Feb 28, 2010 | 0 | n/a |
| Feb 28, 2009 | 0 | n/a |